Syntal Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Syntal Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-290	Closed	-$17K	–	80
2015 Q3	$17K	Hold	290	–	–	0.02%	118
2015 Q2	$19	Buy	290 +30	+12%	+$1.98K	0.02%	136
2015 Q1	$16K	Buy	+260	New	+$16.3K	0.02%	146
2014 Q4	–	Sell	-200	Closed	-$10K	–	161
2014 Q3	$10K	Hold	200	–	–	0.01%	181
2014 Q2	$9K	Buy	+200	New	+$9.86K	﹤0.01%	199

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Syntal Capital Partners's BMY Position: Q4 2015 in Review

Syntal Capital Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 290 shares — an estimated $17K sold.

Syntal Capital Partners first reported a position in BMY in Q2 2014 and held it in 5 quarters. The position peaked at $17K in Q3 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Syntal Capital Partners reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
Syntal Capital Partners sold 290 Bristol-Myers Squibb shares in Q4 2015, an estimated $17K.
Syntal Capital Partners first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 5 quarters.
Syntal Capital Partners's Bristol-Myers Squibb position peaked at $17K in Q3 2015.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Syntal Capital Partners's 13F filing for Q4 2015, filed 12 Feb 2016.